- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07930468
Optimal Duration of Urinary Catheterization After Right-Sided Colectomy
Optimal Duration of Urinary Catheterization After Right-Sided Colectomy: Prospective, Randomized, Non-inferiority Trial
The goal of this prospective, randomized trial is to determine the optimal duration of urinary catheterization in patients that receive elective, right-sided colectomy. The main objectives of this study are:
- To compare rates of urinary retention in patients with post operative urinary catheter duration of 0 days and 1 day following right-sided colectomy.
- To compare rates of urinary tract infection (UTI) in patients with postoperative urinary catheter duration of 0 days and 1 day following right-sided colectomy.
Enrolled participants will be randomized to one of two groups, immediate removal of urinary catheter at the conclusion of the operation or removal of urinary catheter on post operative day one.
Visão geral do estudo
Status
Condições
Descrição detalhada
Urinary catheterization is indicated for various operations conducted by colorectal surgeons. This process allows a tube to be inserted into the bladder to provide decompression while the patient is anesthetized. Prolonged urinary catheter placement is associated with urinary retention, urinary tract infections, and increased hospital length of stay. Clinical guidelines recommend urinary catheter discontinuation within 24 hours of operation but there is mixed evidence to support this recommendation. Further, there is a paucity of data that investigates optimal urinary catheter duration in specific colorectal surgery operations.
This prospective, randomized clinical trial aims to identify the optimal urinary catheter duration for patients undergoing elective, right-sided colectomy. Patients will be randomized into two groups: 1) urinary catheter discontinuation at the completion of surgery, or 2) urinary catheter discontinuation on post operative day 1. The primary objective is to compare rates of urinary retention between groups. The investigators hypothesize that patients with immediate urinary catheter discontinuation will have reduced rates of urinary retention and urinary tract infections compared to the group with urinary catheters maintained until post operative day 1.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Sacha Broccard, MD
- Número de telefone: 201-675-8256
- E-mail: Sacha.Broccard@med.usc.edu
Locais de estudo
-
-
California
-
Los Angeles, California, Estados Unidos, 90033
- Keck Medical Center of USC
-
Contato:
- Annabah Glasser, MD
- Número de telefone: 201-675-3256
- E-mail: Annabah.Glasser@med.usc.edu
-
Los Angeles, California, Estados Unidos, 90033
- Los Angeles General Medical Center
-
Contato:
- Annabah Glasser, MD
- Número de telefone: 201-675-8256
- E-mail: Annabah.Glasser@med.usc.edu
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age 18 years or older.
- Scheduled for elective ileocecectomy, right hemicolectomy, or extended right hemicolectomy using an open, laparoscopic, or robotic approach.
- American Society of Anesthesiologists physical status class I-III.
- Ability and willingness to provide written informed consent.
Exclusion Criteria:
- History of urinary tract malignancy.
- Emergent or urgent surgery.
- Right hemicolectomy performed with another major surgical procedure on the same day.
- Genitourinary tract injury during surgery that precludes participation.
- History of urinary retention following a previous procedure, surgery, or urinary catheter removal.
- History of urinary retention that is not being actively treated.
- Neurogenic bladder.
- Chronic indwelling Foley catheter or suprapubic catheter.
- History of cystectomy or a surgically created urinary conduit, including a neobladder or ileal conduit.
- Chronic kidney disease greater than stage 2.
- History of chronic urinary tract infection.
- Current extravesicular or enterourethral fistula.
- Perioperative epidural catheter placement.
- Incarceration.
- Inability or unwillingness to provide informed consent.
- Pregnancy.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Immediate Catheter Removal
Participants will undergo urinary catheter removal immediately after completion of surgery, in the operating room on post operative day 0. |
Removal of the urinary catheter immediately after elective right hemicolectomy before leaving the operating room.
Outros nomes:
|
|
Comparador Ativo: Postoperative Day 1 Catheter Removal
Participants will undergo urinary catheter removal on post operative day 1. |
Removal of the intra-operatively placed Foley urinary catheter on the day after elective right-sided colectomy, post-operative day one.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Percentage of Participants With Post Operative Urinary Retention
Prazo: From initial post operative urinary catheter removal through hospital discharge, assessed up to 90 days.
|
Post operative urinary retention will be identified by inability to void within 8 hours after catheter removal, associated suprapubic fullness and/or tenderness, and a bladder scan volume greater than 300 mL; or by spontaneous voiding with urinary symptoms and a post-void residual volume greater than 300 mL. Symptoms include suprapubic pain or fullness, bladder pressure, incomplete emptying, or straining. |
From initial post operative urinary catheter removal through hospital discharge, assessed up to 90 days.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Percentage of Participants With Urinary Tract Infection
Prazo: From post operative day one through hospital discharge, assessed up to 90 days.
|
Urinary tract infection will be identified by clinical signs or symptoms such as suprapubic pain or tenderness, dysuria, hematuria, or urinary frequency, together with a urine culture showing more than 100,000 colony-forming units/mL of bacteria. Urinalysis and urine culture will be obtained only when infection is clinically suspected. |
From post operative day one through hospital discharge, assessed up to 90 days.
|
|
Postoperative Hospital Length of Stay
Prazo: From post operative day one through hospital discharge, assessed up to 90 days.
|
Number of inpatient hospital days from the day of surgery to the day of discharge. |
From post operative day one through hospital discharge, assessed up to 90 days.
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- HS-25-00655
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Consent does not permit sharing; will revisit
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .